Tetracycline derivatives as anti-inflammatory agents and potential agents in stroke treatment.
Koistinaho
J
J
A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, Neulaniementie 2, 70210 Kuopio, Finland. Jari.Koistinaho@uku.fi
Yrjänheikki
J
J
Kauppinen
T
T
Koistinaho
M
M
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008911:Minocycline / Q000627:therapeutic use; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors; D018696:Neuroprotective Agents / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy*; D013754:Tetracyclines / Q000627:therapeutic use*; D048051:p38 Mitogen-Activated Protein Kinases
D000893:Anti-Inflammatory Agents; D004791:Enzyme Inhibitors; D018696:Neuroprotective Agents; D013754:Tetracyclines; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D008911:Minocycline